https://www.europeanpharmaceuticalreview.com/news/188062/uk-clinical-trial-application-submitted-for-amyloid-targeting-drug/
0
0
10/26/23 at 4:11pm
Organization
European Pharmaceutical Review
36 words
0
Comments
The CTA sent to the MHRA is for a combination drug with the potential to become a cost-effective treatment against early Alzheimer’s.
You are the first to view
Create an account
or login to join the discussion